Tuberculosis News and Research

Latest Tuberculosis News and Research

Examining effects of reduced AIDS funding for Ethiopia

Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development (CGD), and Kate McQueston, a program coordinator at CGD, write in the center's "Global Health Policy" blog that a reduction in AIDS funding to Ethiopia from PEPFAR and the Global Fund to Fight AIDS, Tuberculosis and Malaria "might be warranted due to epidemiological trends and improved efficiency, or might cripple progress as health programs dependent on external donors are cut back."

13 Sep 2012

Old anti-inflammatory drug possible candidate to treat TB

After testing about 5,600 existing medications for their effectiveness against drug-resistant strains of tuberculosis (TB), researchers from Weill Cornell Medical College reported this week in the Proceedings of the National Academy of Sciences that oxyphenbutazone, "an anti-inflammatory medication marketed in the 1950s as Tandearil and still used in veterinary medicine," killed both latent and active TB bacteria in test-tube experiments, the Los Angeles Times' "Booster Shots" blog reports.

13 Sep 2012

RPS honors Aston University professor with Pharmaceutical Scientist of the Year Award

Professor Yvonne Perrie, Chair in Drug Delivery at Aston University, Birmingham UK has won the prestigious Royal Pharmaceutical Society's Pharmaceutical Scientist of the Year Award for her contribution to developing a new tuberculosis vaccine.

13 Sep 2012

Devex news analysis examines Democratic, Republican party platforms on foreign policy, including global health

A Devex news analysis examines the Democratic and Republican platform positions on foreign policy following the party conventions, writing, "Even as pocketbook concerns continue to overshadow foreign policy issues on the campaign trail, in both Charlotte and Tampa, top-billed speakers made the case for the U.S. foreign aid program."

12 Sep 2012

First demonstration of newly developed dual humanized FRGTM KO system against malaria

A novel human liver-chimeric mouse model developed at Oregon Health & Science University and Yecuris Corporation has made possible a research breakthrough at Seattle Biomedical Research Institute that will greatly accelerate studies of the most lethal forms of human malaria.

11 Sep 2012

Methodist Hospital develops new technology to rapidly detect drug-resistant TB

Technology developed by scientists at The Methodist Hospital Research Institute could halve the time it takes to diagnose tuberculosis infection, and also tell doctors in a day or two whether the bacteria are drug resistant -- a process that currently takes weeks. Initial tests of the device were recently described in Scientific Reports, a Nature online journal.

11 Sep 2012

Democrats, Republicans can agree on U.S. accomplishments in global health, development

"With back-to-back Republican and Democratic National Conventions, it's natural to focus on our differences," but "I am heartened to see the bipartisan support that exists for U.S. leadership in the world -- particularly for our global development efforts," Dan Glickman, former secretary of agriculture and chair of the Board of the Center for U.S. Global Leadership, writes in a Politico opinion piece.

11 Sep 2012

Oxyphenbutazone can kill drug resistant TB

An off-patent anti-inflammatory drug that costs around two cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant tuberculosis in the laboratory -- a feat few currently approved TB drugs can do, and resistance to those is spreading.

11 Sep 2012

Pathogens identified in majority of childhood CAP hospitalizations

A comprehensive investigation of childhood community-acquired pneumonia in Taiwan has identified at least one pathogen in 85% of previously healthy children.

10 Sep 2012

Wall Street Journal examines drug-resistant TB

The Wall Street Journal examines global efforts to stop the spread of drug-resistant tuberculosis (TB) strains, stating, "Global health officials view the emergence of incurable cases of tuberculosis in India as a worrisome evolution in a trend they have been concerned and intensely frustrated about for years -- the rise of drug resistant forms of tuberculosis around the world."

10 Sep 2012

Global Fund must resolve leadership, governance issues by end of 2012

"Good news about the Global Fund to Fight AIDS, Tuberculosis and Malaria has been sorely lacking these past few years as the organization has faced corruption allegations, financial woes, and internal reform," a Lancet editorial states.

7 Sep 2012

Gates foundation blog examines challenges to global TB response

"[O]ver the past month, [tuberculosis (TB)] has captured high-profile attention from the Washington Post, the New York Times, TIME, NPR, [Agence France-Presse] and other major media, generating big headlines about the rising challenge we face in tackling one of humanity's oldest and most resilient infectious diseases," Jan Gheuens, interim director of the Bill & Melinda Gates Foundation's TB Program, writes in the foundation's "Impatient Optimists" blog.

7 Sep 2012

Washington Post examines India's efforts against TB amid fears of drug resistance

The Washington Post examines how the "discovery of an almost untreatable form of tuberculosis [TB] in India has set off alarm bells around the world and helped spur a dramatic expansion of government efforts to battle the killer lung disease."

7 Sep 2012

History of TB policy shows need for care, investment equity in developed, developing countries

In a 200th anniversary article for the New England Journal of Medicine, Salmaan Keshavjee of the Department of Global Health and Social Medicine at Harvard Medical School and Paul Farmer of Partners in Health "seek to elucidate the reasons for the anemic response to drug-resistant tuberculosis [TB] by examining the recent history of tuberculosis policy," they write.

7 Sep 2012

'Toolkit' for African cancer advocates to be launched on September 15

Cancer kills more than seven million people a year throughout the world. This is more than HIV/AIDS, tuberculosis and malaria combined, and African countries, which carry a large part of the burden, are the least able of all developing countries to cope with the challenges it presents, says a consortium of international cancer organizations.

7 Sep 2012

Better recognition of rising burden of cancer in Africa needed

6 Sep 2012

Antibiotics: facts and fictions: an interview with Dr Philippa Binns, clinical adviser at NPS MedicineWise

Antibiotics are medicines used to treat infections or diseases caused by bacteria, such as some respiratory tract infections (including pneumonia and whooping cough), urinary tract infections, skin infections and infected wounds.

6 Sep 2012

Akonni receives NSF's Phase 2 SBIR Grant to develop Lab-on-a-Film microarray

Akonni Biosystems, a life science tools / molecular diagnostics company that develops, manufactures, and plans to market molecular testing devices for diagnosing infectious diseases and human genetic disorders, announced today the receipt of a $498,780 Phase 2 SBIR Grant from the National Science Foundation (NSF).

6 Sep 2012

PlusNews examines recently approved grants under Global Fund's Transitional Funding Mechanism

PlusNews examines the recently approved grants under the Global Fund to Fight AIDS, Tuberculosis and Malaria's Transitional Funding Mechanism (TFM), stating, "Last week, the Fund announced that 45 new grant applications, from countries such as Burundi, Malawi and Swaziland, have been approved under the TFM."

6 Sep 2012

Developing countries NGO delegation to Global Fund submits report highlighting challenges, recommendations

The Center for Global Health Policy's "Science Speaks" blog discusses a report by the developing countries NGO delegation to the Global Fund to Fight AIDS, Tuberculosis and Malaria, submitted recently to the Global Fund Secretariat.

6 Sep 2012

Tuberculosis News and Research

Latest Tuberculosis News and Research

Examining effects of reduced AIDS funding for Ethiopia

Old anti-inflammatory drug possible candidate to treat TB

RPS honors Aston University professor with Pharmaceutical Scientist of the Year Award

Devex news analysis examines Democratic, Republican party platforms on foreign policy, including global health

First demonstration of newly developed dual humanized FRGTM KO system against malaria

Methodist Hospital develops new technology to rapidly detect drug-resistant TB

Democrats, Republicans can agree on U.S. accomplishments in global health, development

Oxyphenbutazone can kill drug resistant TB

Pathogens identified in majority of childhood CAP hospitalizations

Wall Street Journal examines drug-resistant TB

Global Fund must resolve leadership, governance issues by end of 2012

Gates foundation blog examines challenges to global TB response

Washington Post examines India's efforts against TB amid fears of drug resistance

History of TB policy shows need for care, investment equity in developed, developing countries

'Toolkit' for African cancer advocates to be launched on September 15

Better recognition of rising burden of cancer in Africa needed

Antibiotics: facts and fictions: an interview with Dr Philippa Binns, clinical adviser at NPS MedicineWise

Akonni receives NSF's Phase 2 SBIR Grant to develop Lab-on-a-Film microarray

PlusNews examines recently approved grants under Global Fund's Transitional Funding Mechanism

Developing countries NGO delegation to Global Fund submits report highlighting challenges, recommendations

Forensics and toxicology - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Tuberculosis News and Research

Latest Tuberculosis News and Research

Forensics and toxicology - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in